NPI registry status
Active
2026 NPPES data Plastic Surgery within the Head & Neck (Otolaryngology) Physician NPI 1497174189 MD
Verify on CMS → Blake Raggio, MD
Plastic Surgery within the Head & Neck (Otolaryngology) Physician in Montgomery, Alabama.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 632 in Plastic Surgery within the Head & Neck (Otolaryngology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
581
Medicare Part D claims · 188 beneficiaries · Plastic Surgery within the Head & Neck (Otolaryngology) Physician avg: 403
Generic prescribing
97%
generic claims · 3% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
76.4/100
▼ 7 pts below national avg 83.5 · Above neutral
Industry payments
$214.83
5 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Blake Raggio, MD reported a CMS MIPS final score of 76.4/100 - below the 83.5 national average - and filed 581 Medicare Part D claims in 2024.
- 76.4/100
- MIPS score · -7 vs avg
- 581
- Part D claims, 2024
- 97%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Blake Raggio, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1497174189), first enumerated 04/10/2014.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 581 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 76.4/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$214.83 in reported industry payments (5 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1497174189 · Plastic Surgery within the Head & Neck (Otolaryngology) Physician
NPI-10 · ENUM-MID · TAX-NARROW · MIPS-BELOW · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1497174189
- ENUM-MID 2014
- TAX-NARROW 632
- MIPS-BELOW 76.4/100
- RX-LIGHT 581
- BOOK-THIN 7 in Alabama
- PHOTO-FINISH Jana Podzimek · ±0.1
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Louise Davies · …
Louise Davies
76 MIPS pts
- Raggio · this pr…
Raggio · this provider
76.4 MIPS pts
- Jana Podzimek · …
Jana Podzimek
76.5 MIPS pts
- Michael Reilly ·…
Michael Reilly
76.6 MIPS pts
- Oneida Arosarena…
Oneida Arosarena
76.7 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Blake Raggio, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
76 ≥ 17th percentile 17% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Blake Raggio, MD sits
This provider among plastic surgery within the head & neck (otolaryngology) physician peers
Across the 149 plastic surgery within the head & neck (otolaryngology) physician providers who report both Medicare Part D prescribing and a MIPS quality score, Blake Raggio, MD writes more Part D claims than 70% of them and scores higher on MIPS quality than 26% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one plastic surgery within the head & neck (otolaryngology) physician peer from a representative sample of 60; the gold marker is Blake Raggio, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Blake Raggio, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Blake Raggio, MD?
Below national averagePrimary specialty
Plastic Surgery within the Head & Neck (Otolaryngology) Physician
Medicare Part D claims
581 44% vs specialty avg
MIPS final score
76.4/100 7.1 pts vs avg
Specialty distribution in Alabama
How Plastic Surgery within the Head & Neck (Otolaryngology) Physician compares to other specialties among Alabama providers
Medicare quality performance, MIPS
Blake Raggio, MD's 2023 MIPS final score plotted against the Plastic Surgery within the Head & Neck (Otolaryngology) Physician national average
- MIPS Final Score
- 76.4/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1497174189 |
|---|---|
| Specialty | Plastic Surgery within the Head & Neck (Otolaryngology) Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 04/10/2014 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
76.4158
Final Score
Measured-score avg: 83.5
60.3923
Quality
94
Promoting Interoperability
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Blake Raggio, MD. Source: openpaymentsdata.cms.gov.
Total received
$215
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
Blake Raggio, MD - brand share 3.0%
Plastic Surgery within the Head & Neck (Otolaryngology) Physician average
3% brand-name claims vs 97% generic, on 581 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
581
Total Claims
$15K
Total Drug Cost
188
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 790
- Total Day Supply
- 16,717
- Brand vs Generic
- 3% brand / 97% generic
- Brand Drug Cost
- $5K
- Generic Drug Cost
- $10K
- Opioid Claims
- 28 (4.8% rate)
- Antibiotic Claims
- 44
Patient Demographics
- Average Patient Age
- 71.2 years
- Avg HCC Risk Score
- 1.11
- Gender Split
- 66% female / 34% male
- Age Distribution
- <65: 31, 65-74: 90, 75-84: 53, 85+: 14
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Blake Raggio, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Fluticasone Propio…
Fluticasone Propionate
115 claims
- Ipratropium Bromide
Ipratropium Bromide
49 claims
- Celecoxib 41
Celecoxib
41 claims
- Azelastine Hcl 33
Azelastine Hcl
33 claims
- Montelukast Sodium 32
Montelukast Sodium
32 claims
- Ondansetron Odt 29
Ondansetron Odt
29 claims
- Tramadol Hcl 26
Tramadol Hcl
26 claims
- Famotidine 24
Famotidine
24 claims
| Drug | Claims |
|---|---|
| Fluticasone Propionate | 115 |
| Ipratropium Bromide | 49 |
| Celecoxib | 41 |
| Azelastine Hcl | 33 |
| Montelukast Sodium | 32 |
| Ondansetron Odt Ondansetron | 29 |
| Tramadol Hcl | 26 |
| Famotidine | 24 |
| Mupirocin | 21 |
| Betamethasone Valerate | 18 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Plastic Surgery within the Head & Neck (Otolaryngology) Physician in AL →
All providers in Alabama →
Compare specialties →
Plastic Surgery within the Head & Neck (Otolaryngology) Physician Overview
How Blake Raggio, MD fits within the Plastic Surgery within the Head & Neck (Otolaryngology) Physician landscape nationally.
632
Plastic Surgery within the Head & Neck (Otolaryngology) Physician Providers in US
48
States with Plastic Surgery within the Head & Neck (Otolaryngology) Physician
403
Avg Claims per Provider
Blake Raggio, MD's 581 claims are above the specialty average of 403.
Nationwide Plastic Surgery within the Head & Neck (Otolaryngology) Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Raggio, both outside Alabama so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (76.4 here).
Same NPPES enumeration year (2014)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Plastic Surgery within the Head & Neck (Otolaryngology) Physician Providers in Alabama
Other clinicians with the same primary specialty enrolled in Alabama, drawn from the same CMS NPPES roster as Raggio.
One of 7 Plastic Surgery within the Head & Neck (Otolaryngology) Physician providers enrolled in Alabama, 5 are shown here.
Frequently Asked Questions
What is Blake Raggio, MD's specialty? ▼
Blake Raggio, MD specializes in Plastic Surgery within the Head & Neck (Otolaryngology) Physician and practices in Montgomery, Alabama. Credentials: MD.
How much does Blake Raggio, MD prescribe under Medicare Part D? ▼
In 2024, Blake Raggio, MD wrote 581 Medicare Part D claims totaling $15K in drug costs for 188 beneficiaries.
What is Blake Raggio, MD's Medicare quality score? ▼
Blake Raggio, MD has a CMS MIPS Final Score of 76.4/100 (Quality: 60.4). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Blake Raggio, MD located? ▼
Blake Raggio, MD is located at 1111 OLIVE ST, Montgomery, AL, 36106. Phone: (334) 834-7221.
What is Blake Raggio, MD's NPI number? ▼
Blake Raggio, MD's National Provider Identifier (NPI) is 1497174189, issued on 04/10/2014.
Does Blake Raggio, MD prescribe more brand-name or generic drugs? ▼
Blake Raggio, MD's prescribing is 3% brand-name and 97% generic drugs by claim count, with $5K in brand drug costs.
Does Blake Raggio, MD prescribe opioids? ▼
Yes, Blake Raggio, MD had 28 opioid claims in 2024 with an opioid prescribing rate of 4.8%.
How many Plastic Surgery within the Head & Neck (Otolaryngology) Physician providers are there in the US? ▼
There are 632 Plastic Surgery within the Head & Neck (Otolaryngology) Physician providers across 48 states in the US. The average Plastic Surgery within the Head & Neck (Otolaryngology) Physician provider writes 403 Medicare Part D claims per year.
What drugs does Blake Raggio, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Blake Raggio, MD's most frequently prescribed drugs include Fluticasone Propionate, Ipratropium Bromide, Celecoxib. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Blake Raggio, MD accept Medicare? ▼
Blake Raggio, MD appears in CMS Medicare data with 581 Part D claims and 188 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Blake Raggio, MD's credentials? ▼
Blake Raggio, MD's NPI is 1497174189 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.